Mochida Pharmaceutical acquired 35,300 shares of its own stock through market purchases from May 18 to May 31, 2026, totaling 124,315,000 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4534","jir_company_name":"Mochida Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-06-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/4534-20260601-01.pdf","jir_short_summary":"Mochida Pharmaceutical acquired 35,300 shares of its own stock through market purchases from May 18 to May 31, 2026, totaling 124,315,000 yen.","jir_summary":"### Overview of Capital Policy\nMochida Pharmaceutical acquired 35,300 shares of treasury stock through market purchases from May 18 to May 31, 2026. The total acquisition amount was 124,315,000 yen, based on a resolution at the Board of Directors meeting on March 30, 2026, which planned to acquire up to 530,000 shares (1.50% of issued shares). This acquisition was part of that plan, and while some or all of the purchases could have been withheld depending on market conditions, the acquisitions were successfully completed.\n\n### Impact on Shareholders and Future Outlook\nThis share buyback aims to limit dilution of issued shares and strengthen shareholder returns. Moving forward, the company intends to continue pursuing share repurchases and dividend policies as part of its capital policy to enhance shareholder value. Additional purchases or capital measures may be considered depending on market trends and performance.","jir_financial_highlights":"Number of Shares Acquired: 35,300 shares (Unknown)\nTotal Purchase Price: 124,315,000 yen (Unknown)","jir_category":"","jir_hashtags":"#MochidaPharmaceutical, #ShareBuyback, #JapanStocks","jir_key_figures":"Number of Shares Acquired: 35,300 shares\nTotal Purchase Price: 124,315,000 yen\nAcquisition Period: May 18, 2026 \u2013 May 31, 2026","jir_meta_title":"\u3010Mochida Pharmaceutical\u3011Share Buyback | May 2026","jir_meta_description":"Mochida Pharmaceutical acquired 35,300 shares of treasury stock through market purchases in May 2026, totaling 124,315,000 yen. As part of its capital policy.","jir_og_title":"\u3010Mochida Pharmaceutical\u3011Share Buyback | May 2026","jir_og_description":"Mochida Pharmaceutical acquired 35,300 shares of treasury stock in May 2026, strengthening its capital policy. For details, please see the IR materials.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9404,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-55816","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n